MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

16 Nov 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting arranged by JP Morgan scheduled on 21st November 2023 at 05:30 pm to 06:30 pm at Hyderabad. The type of the meeting is In-person (investor group). No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..